ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLCD Colucid Pharmaceuticals, Inc.

46.525
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Colucid Pharmaceuticals, Inc. NASDAQ:CLCD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 46.525 29.00 46.75 0 01:00:00

Statement of Changes in Beneficial Ownership (4)

12/05/2015 10:24pm

Edgar (US Regulatory)


FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Markham Richard J
2. Issuer Name and Ticker or Trading Symbol

CoLucid Pharmaceuticals, Inc. [ CLCD ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

15 NEW ENGLAND EXECUTIVE PARK
3. Date of Earliest Transaction (MM/DD/YYYY)

5/11/2015
(Street)

BURLINGTON, MA 01803
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/11/2015     C    1520136   A   (1) 1520136   I   By Care Capital Investments III, LP   (2) (3)
Common Stock   5/11/2015     C    25403   A   (1) 25403   I   By Care Capital Offshore Investments III, LP   (2) (4)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Convertible Preferred Stock     (1) 5/11/2015     C         1199841      (1)   (5) Common Stock   1199841   $0   0   I   By Care Capital Investments III, LP   (2) (3)
Series B Convertible Preferred Stock     (1) 5/11/2015     C         20050      (1)   (5) Common Stock   20050   $0   0   I   By Care Capital Offshore Investments III, LP   (2) (4)
Series C Convertible Preferred Stock     (1) 5/11/2015     C         320295      (1)   (5) Common Stock   320295   $0   0   I   By Care Capital Investments III, LP   (2) (3)
Series C Convertible Preferred Stock     (1) 5/11/2015     C         5353      (1)   (5) Common Stock   5353   $0   0   I   By Care Capital Offshore Investments III, LP   (2) (4)

Explanation of Responses:
( 1)  Each share of Series B and Series C Convertible Preferred Stock was convertible at any time at the option of the holder, and converted automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.
( 2)  Care Capital III LLC is the general partner of Care Capital Investments III LP and Care Capital Offshore Investments III LP and as a result, Care Capital III LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Richard Markham, Jan Leschly, Jerry N. Karabelas and David R. Ramsay are the four managing members at Care Capital III LLC, and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons, each of whom disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
( 3)  Represents securities held directly by Care Capital Investments III, LP. The reporting person is a partner in Care Capital Investments III, L.P., and shares voting and investment power with the other partners with respect to all of these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
( 4)  Represents securities held directly by Care Capital Offshore Investments III, LP, an affiliate of Care Capital Investments III, LP. The reporting person is a partner in Care Capital Investments III, L.P., and shares voting and investment power with the other partners with respect to all of these shares. The reporting person may be deemed to be an indirect beneficial owner of the reported securities. The reporting person disclaims any beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
( 5)  The securities did not have an expiration date. The securities converted automatically into shares of the Issuer's Common Stock on a one-for-one basis in connection with the closing of the Issuer's initial public offering.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Markham Richard J
15 NEW ENGLAND EXECUTIVE PARK
BURLINGTON, MA 01803
X X

Care Capital III LLC
47 HULFISH STREET, SUITE 310
PRINCETON, NJ 08542

X

Care Capital Investments III L.P.
47 HULFISH STREET, SUITE 310
PRINCETON, NJ 08542

X

Care Capital Offshore Investments III LP
47 HULFISH STREET, SUITE 310
PRINCETON, NJ 08542

X


Signatures
/s/ Miranda S. Hirner, Attorney-in-Fact for Richard J. Markham (power of attorney previously filed) 5/12/2015
** Signature of Reporting Person Date

/s/ Miranda S. Hirner, Attorney-in-Fact for Care Capital III LLC (power of attorney previously filed) 5/12/2015
** Signature of Reporting Person Date

/s/ Miranda S. Hirner, Attorney-in-Fact for Care Capital Investments III, LP (power of attorney previously filed) 5/12/2015
** Signature of Reporting Person Date

/s/ Miranda S. Hirner, Attorney-in-Fact for Care Capital Offshore Investments III, LP (power of attorney previously filed) 5/12/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

1 Year COLUCID PHARMACEUTICALS, INC. Chart

1 Year COLUCID PHARMACEUTICALS, INC. Chart

1 Month COLUCID PHARMACEUTICALS, INC. Chart

1 Month COLUCID PHARMACEUTICALS, INC. Chart

Your Recent History